------------------------------------------------------------
[link removed]


** Join Us for Our HVAD 2022 Webinar Series
------------------------------------------------------------
May 5, 2022

Dear Advocate,

The 25th anniversary of HIV Vaccine Awareness Day ([link removed]) on May 18 is nearly upon us. Nothing about HIV vaccine research has ever been easy, and this past year has shown us how difficult this research is—and how essential it continues to be.

So, join us for our HVAD webinar series this month ([link removed]) to mark important milestones in HIV vaccine development and discuss the path forward. The series will be chaired by Bill Snow and Stacey Hannah and will offer expert perspective on four angles that are critical to vaccine development: Platforms & Pipelines, Processes and Prospects.

* PLATFORMS & PIPELINES ([link removed])
Wednesday May 18, 2022 @ 10.00am EDT
The miracle of mRNA: What’s possible beyond SARS-CoV-2—understanding mRNA, its history and potential challenges for HIV vaccines.
With Bart Haynes (Duke), Nina Russel (Bill & Melinda Gates Foundation) and Ntando Yola (DTHF)

* PROCESSES ([link removed])
Tuesday May 24, 2022 @ 10.00am EDT
The changed landscape of clinical research: the potential for experimental medicine vaccine trials in the current research environment.
With Gail Broder (HVTN), Pontiano Kaleebu (MRC-UK) and Robin Shattock (Imperial College)

* PROSPECTS ([link removed])
Tuesday May 31, 2022 @ 10.00am EDT
What have we learned, why it matters and what it means? Understanding recent results in HIV vaccine research and implications for the future. Unpacking results from Uhambo and Imbokodo trials and understanding the implications for the current pipeline of products.
With Galit Alter (Harvard), William Kilembe (ZEHRP), Ethel Makila (IAVI) and Mary Marovich (NIAID)


And watch this space for more HVAD resources!

Thanks,
AVAC

P.S.
Stay tuned for more on the “The Choice Agenda” – a new forum for advocacy on the latest in HIV prevention research led by Jim Pickett. In the meantime, r (mailto:[email protected]) each out to Jim (mailto:[email protected]) if you are interested in joining the forum.

============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])